Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-10-21A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-10-20A Two-part Phase 1/2a, Open-label, Dose Escalation Study to Evaluate the Tolerability and Preliminary Antitumour Activity of OPB-111001 in Patients With Advanced Cancers That Are Poorly Responsive to Standard Anticancer Treatment
-
CLINICAL_TRIALS study record update · 2015-10-20Multi-Institutional Inter-SPORE Prostate Biomarker Study
-
CLINICAL_TRIALS study record update · 2015-10-16A Phase III, Multicenter, Randomized, Controlled Study of Maximum Androgen Blockade With vs. Without Zoledronic Acid in Prostatic Cancer Patients With Metastatic Bone Disease
-
CLINICAL_TRIALS study record update · 2015-10-15The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-10-14Dissemination of Prostate Cancer Screening to Primary Care Physicians in African American Communities
-
CLINICAL_TRIALS study record update · 2015-10-14Role of PET/CT With Fluorine-18 Tracers and of Diffusion Weighted Whole-body MRI in the Early Detection of Bone Metastases in Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-10-05A Phase 1 Ascending-dose Study to Assess the Safety and Tolerability and Imaging Potential of Hyperpolarized Pyruvate (13C) Injection in Subjects With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-10-05Anti-CTLA4 Blockade Alone or Combined With Systemic GM-CSF for Prostate Cancer Immunotherapy
-
CLINICAL_TRIALS study record update · 2015-10-02A Phase II Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer (47-02-001)
-
CLINICAL_TRIALS study record update · 2015-09-30Prostate Cancer Prevention Trial (PCPT) Companion Long Term Follow Up Study for Men Diagnosed With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-09-30Psychosocial Adjustment During the Post-Radiation Treatment Transition
-
CLINICAL_TRIALS study record update · 2015-09-29A Phase IV, Randomised, Open-label, Multi-centre Study to Assess the Impact on Disease Control, Safety, Patient and Clinician Experience of Changing Patients With Advanced Prostate Cancer From a 3-monthly LHRH Agonist to 6-monthly Injections of Decapeptyl® SR 22.5 MG
-
CLINICAL_TRIALS study record update · 2015-09-23Targeted Biopsies and the Role of Cytological Imprints for Diagnosis of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-09-23Non-comparative, Opened Multicenter Study to Assess the Efficacy and Safety of ELIGARD 22.5mg in the Treatment of Subjects With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-09-22Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections.
-
CLINICAL_TRIALS study record update · 2015-09-18An Open Label, Phase II, Multicenter Study to Evaluate the Efficacy and Safety of a Recombinant Humanized Antibody to HER2 (Pertuzumab) Administered Every 3 Weeks to Patients With Hormone-Refractory Prostate Cancer Who Have Not Been Treated With Chemotherapy
-
CLINICAL_TRIALS study record update · 2015-09-15A Multicentre, Open, Non-comparative, Phase III Study on the Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 22.5 mg 6-month Formulation in Patients With Advanced Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-09-15Can Tadalafil (Cialis)® Maintain Erectile Function In Patients Treated With External-beam Radiotherapy For Prostate Cancer? A Randomized, Double-blind, Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2015-09-11Post-prostatectomy Daily Target Guided Radiotherapy Using Real-Time, State-of-the-Art Motion Tracking With the Calypso 4D Localization System: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2015-09-04Phase II: An Open-Label Extension Study of 168-Hour Continuous Infusion of YM155 in Subjects Previously Enrolled in a Phase I or Phase II Protocol Administering YM155
-
CLINICAL_TRIALS study record update · 2015-08-31Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
-
CLINICAL_TRIALS study record update · 2015-08-26A Phase II Trial of Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising Prostate Specific Antigen (PSA) After Local Therapy
-
CLINICAL_TRIALS study record update · 2015-08-2468Ga-NOTA-AE105. Evaluation of a New Radiotracer Targeting uPAR (Urokinase Plasminogen Activator Receptor), for Positron Emission Tomography Imaging of the Invasive Cancer Phenotype. First in Human
-
CLINICAL_TRIALS study record update · 2015-08-19Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in the Netherlands